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 Successful regeneration of the cranium in patients suffering from cranial bone defects is an 
integral step to restore craniofacial function. However, restoration of craniofacial structure has been 
challenging due to its complex geometry, limited donor site availability, and poor graft integration. 
To address these problems, we investigated the use of a thiol-acrylate hydrogel as a cell carrier to 
facilitate cranial regeneration. Thiol-acrylate hydrogels were formulated with 5–15 wt% 
poly(ethylene glycol)-diacrylate (PEGDA) and 1–9 mM dithiothreitol (DTT). The degradation rate, 
swelling ratio, and shear modulus of the resulting hydrogel were first characterized. Then, pre-
osteoblast-like cells (MC3T3-E1) were encapsulated in the hydrogel and cultured for up to 21 days. 
Our results demonstrate that compared to samples formulated from 15wt% PEGDA, 5wt% PEGDA 
samples showed lower storage modulus at day 10 (0.7kPa vs. 8.3kPa), 62.7% higher in weight 
change after soaking for 10 days. While 5wt% PEGDA group showed an 85% weight loss between 
day 10 and 21, 15 wt% PEGDA group showed a 5% weight gain in the same time period. Cell 
viability with 15wt% PEGDA and 5 mM DTT hydrogel decreased 41.3% compared to 5wt% 
PEGDA and 5mM DTT gel at day 7. However, histological analysis of cells after 21 days in culture 
revealed that they had pericellular mineral deposition indicating that the cells were differentiating 
into osteoblasts lineage in all experimental groups. This study shows that thiol-acrylate hydrogels 
can be tailored to achieve different degradation rates, in order to enhance cell viability and 
differentiation. Thus, the findings of this study provide a fundamental understanding for the 
application of thiol-acrylate hydrogels in cranial bone regeneration. 
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1. Introduction  
 Biodegradable hydrogels are an attractive class of engineered materials that have been 
widely used in several medical fields. These materials have gained wide attention in the tissue 
engineering field due to their resorbability and potential as cellular carriers and/or drug delivery 
vehicles (Reddy et al., 2005, Yang et al., 2010). In the tissue engineering field, there is a sustained 
effort to design and develop hydrogel platforms with appropriate mechanical properties and a 
predictable degradation behavior for multiple applications (Shih and Lin, 2012). Many classes of 
hydrogels have been explored for these applications and among them the poly(ethylene glycol) 
(PEG)- hydrogel has attracted the attention of many biomaterial engineers due to the easy access 
of the commercially available macromers as well as the simplicity in macromer synthesis. 
Additionally, many applications desire the flexibility of PEG-hydrogels that allow the addition of 
a variety of termini during synthesis (Hern and Hubbell, 1998, Bryant et al., 2000, Elbert and 
Hubbell, 2001, Ward and Peppas, 2001, Lin-Gibson et al., 2004, Weber et al., 2006, Hao et al., 
2014, Lin and Anseth, 2009a, Bahney et al., 2011). Previously, visible light-mediated crosslinking 
of degradable hydrogels was developed by using linear poly(ethylene glycol)-diacrylate (PEGDA) 
as the backbone macromer, non-cleavage type photosensitizer eosin Y  as the initiator, and 
bifunctional dithiothreitol (DTT) as the co-initiator and crosslinker (Hao and Lin, 2014, Hao et al., 
2014). In this system, the incorporation of thiol groups into the PEGDA hydrogel resulted in a thiol-
ether-ester bond that allows bulk hydrolytic degradation (Lin et al., 2015). Because the PEGDA 
backbone lacks biological motifs, the cell adhesion peptide, Cys-Arg-Gly-Asp-Ser (CRGDS), was 
added to the prepolymer solution for incorporation into the network structure (Hern and Hubbell, 
1998, Sokic and Papavasiliou, 2012, Li and Kao, 2003, Yang et al., 2005).  Furthermore, a co-
monomer, N-vinylpyrrolidone (NVP) was added to the prepolymer solution, not only to accelerate 
the gelation process, but also to enhance the mechanical stiffness of the hydrogel (Fratzl-Zelman 
et al., 1998, Sokic and Papavasiliou, 2012, Shih and Lin, 2012, Papavasiliou et al., 2008). This 
visible light thiol-acrylate system uses a mixed-mode (step-and-chain) growth mechanism (Hao et 
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al., 2014, Hao and Lin, 2014). Under these conditions, a thiyl radical generated by a proton 
extracted from a photo-excited eosin Y, attacks the vinyl groups present on PEGDA to generate a 
carbon radical, which propagates through another acrylate to permit chain-transfer events or 
extracts hydrogen from another thiol to permit a step-growth thiol reaction (Hao and Lin, 2014). 
The advantage of this gelation mechanism over other thiol-acrylate gelation mechanisms, is the use 
of a biocompatible, non-cleavage, visible light initiator eosin Y. Furthermore, in this system, the 
bifunctional thiol, DTT, serves both as a cytocompatible co-initiator and a cross-linker of the 
PEGDA hydrogel matrix. The use of DTT and eosin Y to initiate and promote gelation has unique 
advantages compared to other initiators used to initiate gelation processes. The most important is 
the toxicity generated by cleavage type initiators, such as I-2959, or the co-initiators such as 
triethanolamine (Hao and Lin, 2014, Shih and Lin, 2012, Hao et al., 2014).  
Degradation rate of a hydrogel cell carrier is critical for the success of cell delivery. The 
carrier should last long enough for the encapsulated cells to proliferate and differentiate; however, 
it should degrade in time and allow native tissue matrices to develop (Anseth et al., 2002, Bryant 
and Anseth, 2002, Lin and Anseth, 2009b). The advantage of using a synthetic hydrogel is the 
ability to design and control the degradation rate based on a target application. In previous studies, 
several parameters such as the concentrations of the co-monomers NVP, DTT, and the types of 
pendent peptide were shown to affect the degradation behaviors of hydrolytically degradable 
PEGDA hydrogels (Hao and Lin, 2014, Lin et al., 2015, Hao et al., 2014). It is known that the cell-
material interaction is dependent on the type of cells encapsulated within the hydrogels. Although 
promising results have been reported with encapsulated hepatocytes(Hao and Lin, 2014), additional 
investigation is required to tailor the gel properties in order to explore the use of appropriate cell 
types for bone regeneration.  
 The aim of this study is to explore the use of photopolymerized PEGDA hydrogel for a 
non-load bearing bone defect application. Although great progress has been made on the use of 
PEGDA hydrogels, additional studies are needed to tailor and improve these hydrogels. In this 
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study, we examine the effects of PEGDA macromers and the concentration of DTT on the 
mechanical stiffness and degradation rate of the formed hydrogel in the context of cranial tissue 
engineering. The cytocompatibility of thiol-acrylate hydrogel is also evaluated using in situ 
encapsulation and differentiation of a pre-osteoblast like cell line (MC3T3-E1).   
2. Materials and Methods
2.1 Materials 
PEG (6 kDa), DTT, N-vinylpyrrolidone (NVP), eosin-Y disodium salt, von Kossa staining 
kit, ascorbic acid, and β-glycerophosphate disodium salt hydrate were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Peptide sequence (CRGDS) was purchased from Thermo Fisher 
Scientific (Rockford, IL, USA). Dulbecco's Phosphate-Buffered Saline (DPBS) and 0.25% Trypsin 
were purchased from Fisher Scientific (Fisher Scientific, Indianapolis, IN). AlamarBlue cell 
metabolic activity kit was obtained from AbD Serotec (Raleigh, NC, USA). Live/dead staining kit 
and Minimum Essential Medium Eagle Alpha (αMEM) were obtained from Life Technologies 
(Grand Island, NY, USA).   
2.2 Methods 
2.2.1 Poly(ethylene glycol)-diacrylate Macromer Synthesis 
PEGDA was synthesized following an established protocol as described previously (Hao 
et al., 2014, Hao and Lin, 2014). Briefly, chemical reactions were completed between 
azeotropically dried PEG-hydroxyl (PEG-OH) and triethylamine, by adding the later slowly into 
the PEG/toluene solution with continuous stirring. Following the initial reaction, acryloyl chloride 
was added to the PEG/toluene solution in drops through an addition funnel. The reaction was 
allowed overnight in the dark in the presence of nitrogen. To remove the triethylamine salt, the 
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mixed solution was filtered using a flask containing neutral aluminum oxide and sodium carbonate. 
Then, the heterogeneous solution was stirred for 2 h, followed by filtration via a thin layer of Hyflo, 
rotovap, and precipitated in cold ether and the extracted PEGDA macromers were characterized by 
HNMR (AVANCE Bruker 500). All PEGDA used in this study had a degree of functionalization 
between 93-96%.    
2.2.2 Hydrogel Swelling Ratio and Degradation  
 Thiol-acrylate hydrogel was prepared by visible light initiated photopolymerization. 
Briefly, a stock solution containing the photo-sensitizer (Eosin-Y), co-monomer (NVP), and cell 
attachment peptides (CRGDS) was prepared in 1X DPBS at pH 7.4.  PEGDA macromers were 
added to the stock solution to obtain final concentrations of 5, 7, 9, 12, or 15 wt%. DTT was then 
added to obtain solutions with final concentrations of 1, 3, 5, 7, or 9 mM. In all solutions, the final 
concentrations of all other components remained identical (0.67 mM of CRGDS peptide, 0.1 mM 
of Eosin-Y, and 0.2% of total solution volume of NVP). Each hydrogel sample was prepared by 
adding 25 µl of pre-polymer solution containing different concentrations of PEGDA macromers 
and DTT into a 1 mL topless cylinder shaped syringe. Then, the samples were exposed to halogen 
cold light (400–700 nm, AmScope, Inc.) for 9 min at 90 KLux. For each group (3 samples per 
group), hydrogels were prepared. The hydrogel samples from each group were then dried in a 
vacuum desiccator for 48 h, weighed, and soaked in DPBS (pH 7.4) and maintained in a 95% 
humidified air incubator at 37˚C. After 4 h, the samples were weighed to record day 1 data. 
Subsequently, PEGDA samples were weighed every 24 h for 21 days. The weight change 
percentage of the soaked gel (q) was calculated from the weights of the swollen sample (Wt) and 
the dry sample (Wo) (Eq. 1).  
q = (Wt−Wo)
Wo
                                                                                                                               (1) 
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2.2.3 Oscillation Rheometry 
To characterize gel stiffness, a Bohlin CVO 100 digital rheometer was used. Samples were 
prepared by injecting aliquots of pre-polymer solutions containing various amounts of PEGDA 
macromers (5, 7, 9, 12 or 15 wt%), 0.67 mM CRGDS, 0.1 mM Eosin-Y, 0.2 volume% NVP, and 
5 mM DTT onto glass slides separated by 1 mm Teflon spacers. After gelation, disc-shaped 
hydrogels with 8 mm diameter were created using a biopsy punch. The discs were then transferred 
into 6-well plates containing DPBS (pH. 7.4) and incubated at 37 C˚. Shear modulus (G’) and loss 
modulus (G”) of hydrogel discs from each group were measured at predetermined time-points 
(days, 1, 3, 5, 8, and 10) by using an oscillatory rheometry operating in strain sweep mode (0.1–
5%) at 1 Hz frequency, using a parallel plate geometry (8 mm) with a gap size of 800 μm. The 
average values of G’ and G” were obtained from the linear portion of the shear modulus-strain 
curves (D'Este and Eglin, 2013, Zustiak and Leach, 2010).  
 
2.2.4 MC3T3-E1 Cell Culture and Encapsulation 
 Pre-osteoblast like cells (MC3T3-E1 cells, ATCC®, Manassas, VA, USA) at passage 4 
were used in this study. In brief, cells were cultured in 150 ml basal αMEM containing 10% Fetal 
Bovine Serum (FBS, HyClone®), 1% penicillin/streptomycin (HyClone®, Logan, Utah, USA), 
and 1 µg/mL amphotericin B (Life Technologies). Cells were maintained at 37 C˚ and 5% CO2 in 
an incubator with 95% humidity. Culture medium was refreshed twice every week.  
 MC3T3-E1 cells were collected at 80% confluency by trypsinization and suspended in 
sterile 1X DPBS (pH 7.4). Then, 2x106 cells pooled from four samples per group were mixed in 
previously prepared (see above) pre-polymer solutions containing various amounts of PEGDA 
macromers (5, 7, 9, 12 or 15 wt%), 0.67 mM CRGDS, 0.1 mM Eosin-Y, 0.2 volume% NVP, and 
5 mM DTT. From each group, aliquots of 25 µL well-mixed pre-polymer solution with cells were 
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injected into 1 mL topless syringes. The samples were then exposed to cold halogen lamp 
illumination for 9 min at 90 kLux to form a cylinder shaped gel that was 2 mm high and 4.5 mm in 
diameter. Cell-laden hydrogels were transferred into 24-well plates and cultured in basic αMEM 
or osteogenic αMEM containing 50 µg/mL ascorbic acid and 10 mM β-glycerphosphate. These 
hydrogels were maintained at 37 C˚ and 5% CO2 in an air incubator with 95% humidity. Medium 
was refreshed every two days. Finally, samples were harvested at various predetermined time-
points according to the experiment. All chemicals and reagents were prepared fresh on the day of 
the experiment.      
2.2.5 Cell Viability Assay  
 Viability of encapsulated MC3T3-E1 cells was assessed quantitatively by measuring 
cellular metabolic activities using a 10% AlamarBlue reagent assay. Qualitative measurement of 
cell viability was performed by staining hydrogels with Calcein AM Live/Dead assay (Life 
Technologies) and observation through a confocal microscope. At least three samples were used in 
each of the following experiments and each experiment was conducted three times.  
2.2.5.1 Metabolic Activity Assay 
 On days 1, 3, and 7, the cell culture medium was removed and hydrogels were washed 
three times with 1X DPBS. Next, 10% AlamarBlue solution was added to each sample and 
incubated for 3 h. Finally, 150µl from each sample was placed in a 96-well plate to measure 
absorption at 570 and 600 nm using a microplate reader.  
2.2.5.2 Live/Dead Assay 
 On days 1 and 7, cell-laden hydrogels from each group were harvested and transferred to 
a 24-well plate. Then, all samples were rinsed three times with 1X DPBS and incubated for 30 min 
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in a mixed buffer containing 0.25 µL/mL calcein AM (green staining for live cells), and 2 µL/mL 
ethidium homodimer-III (red staining for dead cells). After 30 min in the staining buffer, cell-laden 
gels were rinsed once with 1X DPBS at 37 C˚ prior to imaging using a laser scanning confocal 
microscope (Olympus Fluoview, FV1000). Three images were taken per hydrogel in different 
orthogonal.     
2.2.6 Osteogenic Differentiation of Photoencapsulated MC3T3-E1 cells 
 Ability of  the encapsulated MC3T3-E1 cells to differentiate into osteoblasts lineage was 
quantified by examining alkaline phosphatase (ALP) activity (an early marker for osteoblast 
differentiation) and by further histological evaluation of samples by double staining with toluidine 
blue to stain the nucleus and Von-Kossa to stain calcium deposits. Cell-laden hydrogels were 
cultured in basal αMEM or osteogenic αMEM, and were incubated at 37°C, 5% CO2, and 95% 
humidity. The culture medium was refreshed every 2 to 3 days.  
2.2.6.1 Alkaline Phosphatase (ALP) Activity 
 On days 1, 3, and 7, cell-laden hydrogels were rinsed three times with 1X DPBS and gently 
transferred to 2 mL flat-bottom microcentrifuge tubes containing 100 µL radio-
immunoprecipitation assay (RIPA) lysis buffer. Then, the hydrogels were homogenized to enable 
lysis of cells in the gel and protein solubilization. Homogenized cell suspensions were centrifuged 
and the supernatants from each sample was used to measure absorbance at 405 nm using an Epoch 
plate reader (BioTek, Winooski, VT) to determine ALP activity. Finally, ALP activity was 
normalized to total protein concentration in each sample measured at 562 nm. 
 
2.2.6.2 Histology: von-Kossa and toluidine blue double staining 
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 On day 21, photoencapsulated cells were rinsed three times with 1X DPBS, fixed in 10% 
neutral buffered formalin (NBF) for 24 h and infiltrated with Technovit ® 8100 (Kulzer, South 
Band, IN, USA) according to the manufacturers’ instructions. Samples were embedded in Peel-A-
Way® polyethylene plastic molds and the resulting blocks were sectioned to 5µm thick sections 
using a tungsten carbide knife and HM355s motorized microtome (Thermo Scientific). The sections 
were then mounted on charged glass slides and stained using a modified von Kossa method. Briefly, 
slides were placed in 5% silver nitrate solution and exposed to blue light using the Exakt 530 drying 
and supplemental infiltration unit (Sigma Aldrich ) for 20 min. Slides were then rinsed with DI 
water and placed in 5% sodium thiosulfate for 5 min. All slides were then counter-stained with an 
aqueous solution of 0.1% Toluidine Blue O for 1 min, rinsed with DI water, air dried and cleared. 
Then, samples were mounted on the Eukitt® mounting medium (Sigma Aldrich). Digital images 
were acquired using the Aperio Digital Pathology Systems (Aperio Technologies, Park Center 
Drive Vista, CA). 
2.2.6.3 Extraction of mRNA and quantitative PCR (qPCR) 
 Total RNA was isolated from encapsulated cells to determine the presence of osteoblast 
differentiation markers. At predetermined time points (days 1, 3, and 7), PEGDA hydrogels and 
the 2D culture controls were harvested, and rinsed three times with 1X DPBS. Then, the samples 
were transferred to 2 mL Eppendorf tubes and homogenized in 500 µL of Trizol reagent. Next, 100 
µL chloroform was added to the samples, and incubated for 10 min at room temperature. Later, 
samples were transferred to Phase Lock Gel Heavy 2 mL tubes (Gaithersburg, MD, USA) and 
centrifuged at 10,000 rpm for 15 min at 4 C˚. The supernatant was then carefully transferred to a 
new 1.5 mL centrifuge tube containing 250 µL isopropanol, and then centrifuged at 12,000 rpm for 
10 min at 4˚C. After removing the supernatant 1 mL of 75% ethanol was added to each tube, 
followed by vortex and centrifugation for 5 min. The resulting supernatant was carefully removed 
and further cleaned by using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
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protocol. Finally, the RNA was reverse transcribed to cDNA using the Transcriptor First Strand 
cDNA Synthesis Kit (Roche Life Science). qPCR was performed using the SYBR Master Mix (Life 
technology) and primers for mouse Runt-related transcription factor 2 (Runx2) and collagen type 
I. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the endogenous control. The 
reactions were carried out in a 96-well plate (MicroAmpTM, Applied Biosystems, Foster City, CA) 
using a qPCR system (Applied Biosystems, Foster City, CA). The sequences of primers used in 
qPCR are listed here.  
 
 
Primer Forward Sequence Reverse Sequence Runx2 5’-CGACAGTCCCAACTTCCTGT-3’ 5’-CGGTAACCACAGTCCCATCT-3’ Collagen type I 5’-ACGTCCTGGTGAAGTTGGTC-3’ 5’-CAGGGAAGCCTCTTTCTCCT-3’ GAPDH 5’-CGTGGGGCTGCCCAGAACAT-3’ 5’-TCTCCAGGCGGCACGTCAGA-3’ 
 
3. Statistical Analysis 
 All data are presented as mean ± SD. Statistical significance of the differences between 
groups were determined by student’s t-test or a one-way ANOVA, followed by Tukey’s post hoc 
analysis. Differences between groups were considered significant at p < 0.05. All experiments were 
done independently for at least three times with different cell population; prepolymer solutions 
were prepared fresh at every individual experiment.  
4. Results   
4.1 Hydrogel Swelling Ratio and Degradation  
 To evaluate the swelling properties and degradation behavior of PEGDA hydrogels, we 
compared dry and wet weights of each group over a 21 day period. Figure 1A illustrates the gelation 
kinetic process in this study.  Figure 1B illustrates the structure of the formed gel with and without 
cells. Figure 1C illustrate macroscopic appearance of the PEGDA hydrogels constructs with (left 
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hand) and without (right hand) encapsulated MC3T3-E1 cells line. Figures 1D-H show the 
percentages of weight change in soaked hydrogels with increasing thiol concentrations, except for 
the 9 mM DTT in the 5wt% PEGDA group, where the gel did not form. Furthermore, Figures 1D-
H demonstrate the impact of bifunctional thiol concentrations and PEGDA macromers, respectively 
on weight change as a function of soaking time. The first region in Figures 1D-G that show 
hydrogels cross-linked with 5–9 mM DTT is notable between 1–15 days post-gelation. During this 
period, the percent weight change of hydrogels in the various groups increased over time until it 
reached the equilibrium stage, where cross-linked macromers can no longer extend to allow for 
water molecules to infiltrate. The second region shows a slight decrease in weight between 15 and 
21 days post-incubation, indicating the first sign of bulk hydrolytic degradation of the network 
structure. On the other hand, 15wt% PEGDA hydrogel groups cross-linked with different DTT 
molarities, as well as all other PEGDA groups, cross-linked with 1 and 3 mM DTT, demonstrating 
a more linear relationship in the percentage weight change during the 21 days in culture.  
Furthermore, the most notable weight loss is seen in 5wt% PEGDA with 5 and 7 nM DTT and also 
in 7 wt% PEGDA with 9 mM DTT, indicating the degradation and disintegration of the hydrogel.  
 Shown in Table 1A is the ratio of thiol:acrylate in the 5% PEGDA group at various DTT 
concentrations. It is evident that with 5wt% PEGDA, a gel was formed in DTT concentrations at 
or lower than 7mM, but not at 9 mM. These results demonstrate that a thiol:acrylate ratio of 0.84 
but not 1.08 would allow gel formation. Furthermore, weight loss before 21 days in culture is 
observed at thiol:acrylate ratio from 0.6-0.84 .  
4.2 Oscillatory Rheometry 
 Figure 2A shows the effects of PEGDA macromer content on the shear modulus of the 
resultant gel. Increasing PEGDA macromer concentration increased the shear moduli in all 
hydrogel groups. Furthermore, a gradual decrease in the shear moduli of the resultant hydrogels 
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was observed over time due to hydrolytic degradation.  
 Figure 2B shows differences between the storage moduli of 𝐺𝐺′ and the respective loss 
moduli of 𝐺𝐺′′ by more than one order of magnitude in each group thus confirming the success of 
gelation (only 5%, 9% and 15% groups are shown).  
Overall, compared to samples formulated from 15wt% PEGDA with 5 mM DTT, 5wt% 
PEGDA samples with 5 mM DTT showed lower storage modulus at day 10 (0.7kPa vs. 8.3kPa) 
62.7% higher in weight change after soaking for 10 days. While 5wt% PEGDA group showed a 
85% weight loss between day 10 and 21, 15 wt% PEGDA group showed a 5% weight gain in the 
same time period. 
 
4.3 Effect of PEGDA Macromer Concentrations on Degradation Rate 
 We then evaluated the degradation rate of the hydrogels through the change in shear 
modulus with time as described previously (Hao and Lin, 2014, Hao et al., 2014). The degradation 
rates in all groups followed a pseudo first order degradation kinetics equation:  ln � G′
G′0
� =  −kt                                                                                                                               (2)  
where G’0 and G’ represent shear modulus of hydrogels on day 1 and at all other time-points of the 
experiment, respectively. 𝑘𝑘 is the degradation rate constant and 𝑡𝑡 represents the degradation time. 
In Figure 3, Ln� G
′
G′0
� was plotted as a function of time (days). The results show that the exponential 
decay curve of all thiol-acrylate hydrogels followed a pseudo first order degradation kinetics. 
Similarly, Table 2 illustrates the calculated degradation rate constants (𝑘𝑘). 
4.4 Preosteoblast Cell Viability of MC3T3-E1 Cells 
14  
4.4.1 Metabolic Activity Assay 
 The mitochondrial metabolic activity of MC3T3-E1 cells encapsulated in hydrogels was 
measured by the capacity to reduce the AlamarBlue reagent. Figure 4A shows no significant 
differences in the cell metabolic activities of all groups on day 1 post-gelation. Conversely, on days 
3 and 7 post-gelation, the 5 wt% PEGDA group shows significantly higher metabolic activities 
than the other PEGDA hydrogel groups. Interestingly, the metabolic activity in the 15 wt% PEGDA 
group remained similar at all time-points, with no statistically significant difference found on days 
1, 3 and 7. 
4.4.2 Live/Dead Assay 
 Figure 4B shows the viability of MC3T3-E1 cells encapsulated in hydrogels containing 
different concentrations of PEGDA macromers.  High cell viability can be observed in all PEGDA 
hydrogel groups on day 1 with only small amount of dead cells (red cells) visible in the 12 and 15 
wt% groups (3 samples for each group were imaged, each sample was imaged in at least 3 different 
areas). Furthermore, live/dead staining revealed that cells tend to form small clusters with 
increasing PEGDA macromer concentrations. However, higher cell viability (more green cells) was 
observed in the 5 and 7 wt% PEGDA groups on day 7 compared to the 9, 12, and 15 wt% PEGDA 
groups, which contained more dead cells (red).   
4.5 Osteogenic Differentiation of Photoencapsulated MC3T3-E1 cells 
4.5.1 Alkaline Phosphatase (ALP) Activity 
 Figure 5A shows the effect of osteogenic induction on the ALP activity of MC3T3-E1 cells 
encapsulated in 5% and 15% PEGDA gels for 7 days. Statistically significant difference is not 
observed in the ALP activities of MC3T3-E1 encapsulated in 5wt% and 15wt% PEGDA on days 1 
and 3. The positive control group with a 2D cell culture illustrates significantly higher ALP activity 
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compared to the 15 wt% PEGDA group on day 7. Nevertheless, there is no significant difference 
between the cells in 2D culture and those in 5 wt% PEGDA on day 7. 
4.5.2 Histological Sectioning: von-Kossa and toluidine blue double staining 
 Figure 5B shows the histological sections of MC3T3-E1 cells encapsulated in PEGDA 
hydrogels. Von Kossa staining was used to investigate calcium deposits (black) and toluidine blue 
was used to label nuclei (blue). As expected, all groups cultured in the osteogenic medium 
demonstrated pericellular calcium deposits proximal to the blue stained cell nuclei. Since 5 wt% 
PEGDA is a fast degrading hydrogel, cells migrated into nearest surface (dish culture surface) to 
continue to differentiate and to deposit sufficient amounts of calcium during gel degradation. In 
contrast, no calcium staining is observed in groups cultured in basal medium, although toluidine 
blue stained cell nuclei are clearly visible. 
4.6 Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) 
 To further examine cell differentiation status, we preformed RT-qPCR to monitor the 
expression of two osteogenic genes, Runx2, and collagen type I, in MC3T3-E1 cells encapsulated 
in 5 wt% PEGDA, 15 wt% PEGDA, and in cells in the 2D culture positive control. Figure 6A 
shows the expression of Runx2 at three early time-points, day 1, day 3, and day 7, in cells cultured 
in the osteogenic differentiation medium. Although no significant difference can be observed 
between the groups on days 1 and 3 post-gelation, Runx2 expression is significantly upregulated 
on day 7 in MC3T3-E1 cells encapsulated in 5 wt% PEGDA compared to 15 wt% PEGDA (p < 
0.05) and the 2D culture (p < 0.01) groups. The expression of Runx2 increased 1.9-fold compared 
to the 1.25- and 0.5-fold change in the cells in the 15 wt% PEGDA and 2D culture groups, 
respectively. Interestingly, Figure 6B shows that collagen type I was significantly upregulated on 
day 3 in both 15 wt% PEGDA and 2D culture groups compared to the 5 wt% PEGDA group. 
However, on day 7 these differences between the experimental groups were not statistically 
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significant.  
5. Discussion  
5.1 Mixed-mode Thiol-acrylate Reaction 
 Previously, it was reported that the gelation of visible light based thiol-acrylate hydrogel 
occurs through a mixed-mode step-chain growth polymerization mechanism (Hao et al., 2014). The 
process is initiated by exposing a prepolymer solution to visible light to allow the formation of thiyl 
radicals through eosin-Y-mediated proton abstraction. The thiyl radicals attack vinyl groups on 
PEGDA macromers to form carbonyl radicals and allow their propagation through other acrylates 
by chain-growth homopolymerization or by reacting with other thiols to allow step-growth 
addition, resulting in a mixed-mode step-chain growth polymerization mechanism (Figure 1A) 
(Hao et al., 2014). The incorporation of thiol groups into PEGDA hydrogel imparts a thiol-ether-
ester bond that makes bulk hydrolytic degradation possible and increases gel swelling ratio over 
time (Lin et al., 2015). The mechanism of PEGDA hydrogel gelation, stiffness, and degradation 
depend on several factors, including the concentrations of the NVP monomers and the CRGDS 
peptide. In this report, we evaluated the effects of tuning the PEGDA and bifunctional thiol 
concentrations while maintaining the concentrations of other components stable (i.e. 
photosensitizer eosin-Y, NVP, and CRGDS peptide) to achieve the degradation time and stiffness 
needed to efficiently encapsulate cells suitable for cranial regeneration.  
 
5.2 Effects of Bifunctional Thiol on Swelling Kinetics and Degradation of Visible Light-Cured 
Thiol-Acrylate Based Hydrogel 
 The network structure of thiol-acrylate hydrogel initiated by visible light 
photopolymerization incorporates the co-monomer NVP, thiol-containing an active peptide of 
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CRGDS that is chemically bound to the hydrogel backbone through the formation of thiol-ether-ester linkage as seen between DTT and PEGDA backbone(Hao and Lin, 2014), and 
bifunctional thiol, into the PEGDA network structure. To examine the effects of PEGDA and DTT 
concentrations on the weight change in soaked hydrogel samples, we prepared thiol-acrylate 
prepolymer solutions using different concentrations of PEGDA macromers (5, 7, 9, 12, and 15 
wt%) and various concentrations of DTT (1, 3, 5, 7, and 9 mM). The concentration of all other 
components in the matrix were fixed (photosensitizer eosin Y - 0.1 mM, NVP - 0.2%, and CRGDS 
peptide - 0.67 mM).  
 After initiation, the bifunctional thiol can participate in the gelation process by chain-
growth polymerization between thiyl group, PEGDA and NVP macromers. As bifunctional thiol 
concentration increases, the chain transfer events also increase and lead to termination of the 
reaction or formation of the PEGDA-DTT oligomers through step-growth polymerization. As a 
result, the degree of homopolymerization and crosslinking among PEGDA and the number of high 
molecular weight polyacrylate chains decrease (Reddy et al., 2005).  Therefore, decreasing PEGDA 
macromers and increasing the bifunctional thiol can result in increased swelling (Figure 1D-1H). 
At 9 mM of DTT in the 5 wt% group, three-dimensional (3D) network structure no longer forms. 
A previous study clearly reported that NVP is required as a co-monomer to participate in the 
gelation of the thiol-acrylate system due to the low reactivity of the thiyl radicals generated from 
the di-thiol molecules by the visible light-sensitized eosin-Y (Hao et al., 2014). Therefore, when 
DTT level is too high, NVP levels should also be increased to allow DTT to participate in gelation. 
Conversely, the excessive DTT may consume NVP and prevent gel formation similar to the 
conditions at lower DTT concentrations.  
 Tuning the degradation rate of the cell carrier is important for segmental cranial defect 
repair. Several factors must be considered when designing a hydrogel cell carrier. The carrier 
should be 1) biocompatible, 2) closely match the mechanical stiffness of the target tissue, and 3) 
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the carrier should degrade in a time frame that approximates new tissue formation (Chan and Leong, 
2008, Zhang et al., 2014, Verhulsel et al., 2014). Figures 1D-H show the impact of bifunctional 
thiol concentrations and PEGDA macromers, respectively on the percentage weight change as a 
function of degradation time. Degradation of these hydrogels is initiated once the gel is immersed 
in the watery microenvironments via hydrolysis. PEGDA hydrogels tend to gain more weight and 
degrade faster with increasing bifunctional thiol and decreasing PEGDA macromer concentrations. 
This may be a result of more water molecules infiltrating into the network structure leading to an 
increase in weight change that increase the opportunity for hydrolytic degradation. Finally, 
significant weight loss occurs in the network groups with lower PEGDA macromers and higher 
bifunctional thiol concentrations. This can be observed in 5wt% PEGDA with 5 and 7 mM DTT 
15 days post-gelation (Figure 1D).  The 15 days experimental duration in this study that determined 
enough weight loss in the hydrogel to accommodate bone formation was based on the typical 
timeframe for fracture healing i.e., 4-6 weeks. Based on these results, only 5 mM concentration of 
bifunctional thiol was chosen to evaluate stiffness and degradation rate using rheometry.  
5.3 Effect of PEGDA Macromers on the Mechanical Stiffness of Thiol-acrylate Hydrogels 
 Figure 2A shows the shear moduli of hydrogels formed by various PEGDA macromer 
concentrations. When the concentrations of all other components (e.g. RGDC peptide, bifunctional 
thiol, NVP macromer, and initiator eosin Y) remained constant in the prepolymer solution, the 
storage moduli of the PEGDA hydrogels increase with increasing PEGDA macromer 
concentrations. However, a gradual decrease in the shear moduli is observed over time due to 
hydrolytic degradation. Previous studies have shown that the shear moduli of hydrogels are affected 
by the percentage of NVP macromers (Hao et al., 2014, Hao and Lin, 2014, Lin et al., 2015, Lee et 
al., 2014). Based on these studies, we chose 0.2% NVP peptide, which was shown to increase the 
viability and proliferation of hepatic cells over time (Hao and Lin, 2014). The present study 
illustrates the effects of PEGDA macromer concentrations on the storage moduli of hydrogels. We 
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also examined how the storage and loss moduli were related in the resultant gels on day 1 post-
gelation (Figure 2B). The results show a one order of magnitude difference between the storage 
and loss moduli thus confirming the successful gelation in all 5 groups of PEGDA hydrogels.  
 As expected, increasing PEGDA concentration in prepolymer solutions increased the 
mechanical stiffness of the gels (Figure 2A). This is likely because the mesh size of the gel 
decreased with increasing PEGDA macromers post-gelation.  The relationship between mesh size 
and hydrogel stiffness has been well-established, where increasing mesh size decreases mechanical 
stiffness and vice versa. In this system, 5 wt% PEGDA shows higher swelling kinetic due to 
increase in mesh size where more water molecules can infiltrate. However, the increasing mesh 
size in 5 wt% PEGDA hydrogels also decreased the mechanical stiffness. The opposite was 
observed in 15 wt% PEGDA where the weight change was minimal but higher mechanical stiffness 
is evident. Importantly, the shear modulus of 5% PEGDA hydrogels with 5 mM DTT at 1,886 Pa 
on day 1 demonstrated sufficient mechanical integrity for clinical handling. 
5.4 Effect of PEGDA Macromers on Hydrolytic Degradation of Visible Light-Cured Thiol-
Acrylate Hydrogels  
 We also explored the hydrolytic kinetics of PEGDA hydrogels following thiol-acrylate 
photopolymerization. In this system, thiol-acrylate hydrogels degrade hydrolytically following a 
bulk degradation initiated by the presence of labile thiol-ether-ester bonds present throughout the 
swollen hydrogel network. To model the degradation behavior of hydrogels, we used a pseudo first 
order degradation kinetics equation (Eq. 2), which was used previously to model the degradation 
rates of thiol-acrylate hydrogel system (Fairbanks et al., 2009, Rydholm et al., 2005, Metters and 
Hubbell, 2005, Rydholm et al., 2007). These studies reported that increasing thiol concentrations 
in the thiol-acrylate system could increase the degradation rate of hydrogel although significant 
differences were not observed between all compared groups (Hao and Lin, 2014, Lin et al., 2015). 
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In this study, we show that altering PEGDA macromer concentrations in thiol-acrylate hydrogels 
can significantly affect the degradation rate, as observed between the 5 wt% hydrogel and the other 
groups. Moreover, 5 wt% PEGDA hydrogels with 5 mM DTT rapidly dissolved after day 1 post-
gelation. The main reason for this could be that the mesh size was larger in lower PEGDA hydrogels 
allowing for more water molecules to infiltrate and degrade the gel. Also, the hydrogels with lower 
PEGDA concentrations (5 wt%) simply have higher [SH]/vinyl ratio to allow degradation.  
 
5.5 In Situ Encapsulation and Proliferation of MC3T3-E1 Cells in Visible Light-Cured Thiol-
Acrylate Hydrogels  
 A previous study on visible light-cured PEGDA hydrogels revealed their use to encapsulate 
Huh7 cells (a hepatocyte cell line), which maintained viability, and showed higher proliferation 
rate over time (Hao and Lin, 2014). The focus of this previous study was on adjusting hydrogel 
stiffness based on the concentration of NVP macromers and CRGDS peptides to achieve higher 
hepatic cell viability (Lin et al., 2015, Hao and Lin, 2014). In this study, we used MC3T3-E1 cells 
to demonstrate that it is feasible to maintain viability and induce differentiation in cells 
encapsulated in thiol-acrylate hydrogels. 
 The mitochondrial metabolic activity of photoencapsulated MC3T3-E1 cells in 5 wt% 
PEGDA is higher than other PEGDA hydrogel groups at all time-points. Observation through 
confocal microscopy revealed better cell viability in 5 and 7 wt% PEGDA hydrogels after seven 
days of culture in growth medium; fewer dead cells are seen compared to day 1. However, in 12 
and 15 wt% PEGDA hydrogels a notable decrease in cell viability is observed after culture for 
seven days. It is plausible that increasing PEGDA macromers may have reduced the mesh size, 
which could hinder the diffusion of nutrients into the cells (Bryant et al., 2000, Burdick et al., 2005). 
On the other hand, cells encapsulated in lower concentrations of PEGDA macromers allow for 
better exchange of oxygen and better access to growth factors due to a larger mesh size in the 
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hydrogel. Another important factor related to lower cell viability in hydrogels with higher PEGDA 
concentration is related to free radicals. Mazzoccoli el at studied the effects of low and high 
PEGDA concentrations on cell viability and showed that the concentrations of free radicals 
resulting from the crosslinking process of PEGDA could be a main factor that decreases cell 
viability although other possibilities such as topology and morphology of PEGDA hydrogels cannot 
be ruled out (Mazzoccoli et al., 2010).  
5.6 Photoencapsulated MC3T3-E1 Cell Differentiation and Mineralization 
 Designing hydrogel scaffolds in which encapsulated cells are encouraged to differentiate 
into osteogenic lineages is essential in bone tissue engineering. Optimal hydrogel matrices would 
allow for encapsulated cells to differentiate into target osteogenic lineages, and allow for ECM 
deposition concomitant with hydrogel degradation during an appropriate time-scale. Various 
methods have been studied to enhance cell differentiation in 2D and 3D cell cultures, and include 
designing hydrogel scaffolds with suitable mechanical strength, degradation kinetics, and 
biochemical cues (Wang et al., 2000, Panetta et al., 2009). In this study, we used two in vitro assays, 
ALP activity and mineral deposition through alizarin red staining, to evaluate osteogenic 
differentiation. 
 ALP activity in cells is an early marker for osteoblast differentiation. In the osteogenic 
differentiation medium, ALP activity increases in cells that are capable of differentiating down the 
osteoblast lineage in response to chemical cues such as ascorbic acid and β-glycerol phosphate. 
This has been well-established in 2D cell culture conditions. For this reason, we compared the 2D 
cell culture (positive control), with encapsulated MC3T3-E1 cells in soft (5 Wt% PEGDA) and stiff 
(15 Wt% PEGDA) hydrogels. Figure 5A shows a significant increase in ALP activity in 5 wt% 
PEGDA hydrogels and 2D cell culture compared to cells photoencapsulated in 15 wt% PEGDA 
hydrogels. This increase in ALP activity may be in part, due to higher cell viability in both 5 wt% 
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PEGDA and 2D culture. Furthermore, the higher diffusion of chemical cues through the 5 wt% 
network structure compared to 15 wt% PEGDA could have also likely enhanced differentiation of 
MC3T3-E1 cells into osteoblasts lineage.  
 Typically, calcium deposition represents osteoblast differentiation of cells. In Figure 5B, 
we demonstrate the double staining of mineral deposits in photoencapsulated MC3T3-E1 in 
PEGDA hydrogel sections with von Kossa staining and cell nuclei with toluidine blue staining. 
PEGDA groups cultured in osteogenic medium show pericellular mineral deposits around the blue 
stained cell nuclei, indicating successful differentiation of MC3T3-E1 cells into the target 
osteoblast lineage. However, no calcium staining was visible in the negative control group cultured 
in basal medium. Yang et. al. have also shown similar induction of bone marrow stromal cells 
encapsulated in PEGDA hydrogel to osteoblasts lineage (Yang et al., 2005).  
5.7 Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) 
 Runx2 is an essential gene for osteoblast differentiation. It is upregulated during the early 
stage of osteoblast differentiation and its expression wanes with increased cell differentiation. 
Although proliferation of cells in 2D culture is faster compared to cells encapsulated in 5 wt% 
PEGDA (data not show), our results show that Runx2 expression is significantly upregulated in 5 
wt% PEGDA compared to 2D culture on day 7 (Figure 6A). This higher expression of Runx2 in 5 
wt% PEGDA hydrogels shows the potential of our thiol-acrylate hydrogel as a cell carrier for 
cranial repair.          
  
6. Conclusion   
 
 Optimizing hydrogel scaffolds that promote cell proliferation, differentiation and matrix 
formation is critical for tissue engineered regeneration. In this study, we have prepared and 
examined visible light-cured thiol-acrylate hydrogel with variable mechanical stiffness and 
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degradation rates by altering PEGDA macromer concentrations in prepolymer solutions. The fast 
degrading thiol-acrylate hydrogel based on 5wt% PEGDA not only supports osteoblasts lineage 
differentiation, but also closely matches the mechanical stiffness and degradation profile for our 
target application goal for non-load bearing cranial defects. Based on these findings, our future 
studies will further investigate its use in critical sized cranial defects regeneration in rabbit animal 
models.  
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Figure 1: (1A) Mixed-mode (Step-Chain) growth mechanism of visible light initiated thiol-acrylate 
photopolymerization. (1B) Illustration of formed gel structure. (1C) Illustrate macroscopic 
appearance of the PEGDA hydrogels constructs with (left hand) and without (right hand) 
encapsulated MC3T3-E1 cells line. Effects of PEGDA macromers and bifunctional thiol content 
on the weight change of hydrogels soaked in (1D)-5 wt% PEGDA, (1E)-7 wt% PEGDA, (1F)-9 
wt% PEGDA, (1G)-12 wt% PEGDA, or (1H)-15 wt% PEGDA). (N = 3, mean ± SD).       
 
Figure 2: (2A) Effects of PEGDA macromer concentrations on equilibrium shear moduli. 
Increasing PEGDA concentration increases share moduli at all time-points, a gradual decrease is 
observed in all PEGDA hydrogels due to degradation over time. (2B) A difference by one order of 
magnitude between the elastic modulus (G’) and loss modulus (G”) indicates successful gelation 
of the hydrogel.  
 
Figure 3: Plot of Ln(G’/G’0) as a function of time. A linear relationship indicates that the 
degradation of thiol-acrylate hydrogels follow a pseudo first order degradation kinetics.  
 
Figure 4: Three-dimensional culture of MC3T3-E1 cells in visible light cured PEGDA thiol-
acrylate hydrogels with different PEGDA macromer concentrations. (A) Cell metabolic activity on 
days 1, 3, and 7 for all PEGDA groups. (B) Confocal microscopic images of encapsulated MC3T3-
E1 cells stained with Live/Dead staining on days 1 and 7. Scale bar is 100 µm. * p < 0.05, ** p < 
0.01. 
Figure 5: Osteogenic differentiation of MC3T3-E1 encapsulated in PEGDA hydrogels. (A) 
Normalized ALP activity of encapsulated MC3T3-E1 in osteogenic medium (OST medium) and 
basal medium (BSL medium). (B) von Kossa staining. Cell nuclei are stained blue and calcium is 
stained black. Double staining demonstrates pericellular mineralization of cells cultured in 
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osteogenic medium compared to PEGDA groups cultured in basal medium. Scale bar is 300 µm. * 
p < 0.05. 
Figure 6: Reverse Transcription–qPolymerase Chain Reaction of MC3T3-E1cells encapsulated in 
PEGDA hydrogels. (A) The early osteogenesis marker, Runx2, was upregulated in the 5 wt% 
PEGDA group and the 2D MC3T3-E1 culture. (B) Collagen type I expression on day 3. * p < 0.05, 




Table 1. Formulations of Hydrogels at 5% PEGDA    
PEGDA 6000 Da (wt%) Acrylate (mM) DTT (mM) [SH]/Acrylate [SH]/vinyl*                                        Gelation Wt. loss before 600 hr 5  16.7 1 0.12 0.06 Y N 5  16.7 3 0.36 0.17 Y N 5  16.7 5 0.60 0.29 Y Y 5  16.7 7 0.84 0.40 Y Y 5  16.7 9 1.08 0.52 N -- *The vinyl group includes C=C contribution from NVP  
 
Table 2. Formulations of Photoencapsulated PEGDA Hydrogels incorporating bifunctional thiol with 5 mM DTT    
PEGDA 6000 D.a (wt%) Acrylate (mM) [SH]/Acrylate [SH]/vinyl* NVP/Acrylate Modulus on Day 1(Pa) 5 16.7 0.598 0.288  1.077  1886.70  7 23.3 0.429 0.242  0.772  2361.13  9 30.0 0.333 0.208  0.599  5499.81  12 40.0 0.250 0.172  0.449  9598.19  15 50.0 0.200 0.147  0.359  10709.29  *The vinyl group includes contribution from NVP        
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Figure 1: (1A) Mixed-mode (Step-Chain) Growth mechanism of visible light initiated thiol-acrylate photopolymerization. (1B) Illustration of formed gel structure. (1C) Illustrate macroscopic appearance of the PEGDA hydrogels constructs with (right hand) and without (left hand) encapsulated cells line (1D)-5 wt% PEGDA, (1E)-7 wt% 
PEGDA, (1F)-9 wt% PEGDA, (1G)-12 wt% PEGDA, (1H)-15 wt% PEGDA) Effects of 





Figure 2: (2A) Effects of PEGDA Macromer Concentrations on equilibrium shear 








Figure 4: Three-dimensional culture of MC3T3-E1 in visible light cured PEGDA thiol-
acrylate hydrogels with different PEGDA macromer concentrations. (A) Cell 
metabolic activity at days 1, 3 and 7 for all PEGDA groups. (B) Confocal microscopy 











Figure 6: Reverse Transcriptase -qPolymerase Chain Reaction of MC3T3-E1cells 
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